HNX:MED Market Cap

HNX:MED has a market cap or net worth of 228.34 billion as of June 5, 2026. Its market cap has increased by 39.85% in one year.

Market Cap

228.34B

Enterprise Value

231.16B

Revenue

366.83B

Ranking

n/a

PE Ratio

14.42

Stock Price

18,400.00

Market Cap Chart

Since March 18, 2020, HNX:MED's market cap has decreased from 307.72B to 228.34B, a decrease of -25.80%. That is a compound annual growth rate of -4.73%.

Market Cap History

Date	Market Cap	% Change
May 13, 2026	228.34B	-21.70%
Dec 31, 2025	291.64B	-12.96%
Dec 27, 2023	335.07B	28.57%
Dec 26, 2022	260.61B	38.79%
Dec 31, 2021	187.77B	-23.33%
Dec 24, 2020	Upgrade Pro	Upgrade Pro
Mar 18, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Central Pharmaceutical Joint Stock Company No3	1.26T
Pharmedic Pharmaceutical Medicinal JSC	1.21T
Vidipha Central Pharmaceutical JSC	1.19T
Ben Tre Pharmaceutical JSC	237.25B
Vimedimex Medi-Pharma JSC	225.43B
American Vietnamese Biotech Incorporation	196.66B
Phong Phu Pharmaceutical JSC	159.28B
Lamdong Pharmaceutical JSC	157.32B

Market Cap Rankings